Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief
Johnson & Johnson's $1 billion Firefly Bio acquisition highlights a…
Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief
Harbour BioMed partners with Sinopharm to establish an innovation consortium…
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…
Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief
Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…
Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief
Nucleai broadened its University of Glasgow collaboration to expand academic…
Servier Completes Edgewise Muscular Dystrophy Acquisition | Lucid Diligence Brief
Servier Completes the Edgewise Muscular Dystrophy Acquisition and Adds…
United Therapeutics’ Thymmune acquisition | Lucid Diligence Brief
United Therapeutics adds Thymmune’s iPSC thymic-cell platform to its…
Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
Insilico and Takeda test whether Pharma.AI can convert discovery speed into…
SERB–Hansa Idefirix Deal | Lucid Diligence Brief
SERB’s Idefirix rights acquisition from Hansa Biopharma sharpens its rare…
Innovent-Lilly Verzenios China Commercialization | Lucid Diligence Brief
Innovent takes mainland China commercial responsibility for Verzenios as Lilly…
Sickle Cell Gene Therapies Ranked by AI Models | LucidScope AI Visibility Audit
Key Findings from the LucidScope AI Visibility Audit of Casgevy, Lyfgenia,…
Merck KGaA Bio-Techne Deal | Lucid Diligence Brief
Merck KGaA’s US$11.3bn Bio-Techne acquisition tests workflow depth, integration…